Moreover, inhibiting Bruton’s tyrosine kinase (BTK), an upstream activator of the NLRP3 inflammasome, can reduce the infarct volume and associated neurological damage following ischemic stroke [123]. The gene discussed is NLRP3; the disease is ischemic stroke.